These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 11294675

  • 1. Survival of patients with AIDS, after diagnosis of Pneumocystis carinii pneumonia, in the United States.
    Dworkin MS, Hanson DL, Navin TR.
    J Infect Dis; 2001 May 01; 183(9):1409-12. PubMed ID: 11294675
    [Abstract] [Full Text] [Related]

  • 2. [Diagnosis of pneumocystis carinii pneumonia in AIDS patients].
    Armbruster C, Hassl A, Kriwanek S.
    Wien Klin Wochenschr; 1998 Sep 18; 110(17):604-7. PubMed ID: 9816629
    [Abstract] [Full Text] [Related]

  • 3. [Improved prognosis of first episode HIV associated Pneumocystis carinii pneumonia without preventive treatment: etiology and sequelae].
    Ewig S, Schäfer H, Rockstroh JK, Lüderitz B.
    Pneumologie; 1996 Jul 18; 50(7):455-61. PubMed ID: 8927603
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pneumocystis carinii pneumonia in the Federal Republic of Germany in the era of changing antiretroviral therapy - IDKF 13 -. German AIDS Study Group (GASG/IdKF).
    Stoehr A, Arasteh K, Staszewski S, Brockmeyer N, Albrecht H, Mertenskötter T, Jablonowski H, Emminger C, Rockstroh JK, Baumgarten R, Bogner J, Loch T, Plettenberg A.
    Eur J Med Res; 1999 Apr 27; 4(4):131-4. PubMed ID: 10205287
    [Abstract] [Full Text] [Related]

  • 7. Pneumocystis carinii pneumonia.
    Schliep TC, Yarrish RL.
    Semin Respir Infect; 1999 Dec 27; 14(4):333-43. PubMed ID: 10638513
    [Abstract] [Full Text] [Related]

  • 8. [AIDS with inaugural Pneumocystis pneumonia pneumonia. Impact of triple antiretroviral therapy].
    Yousfi M, Boibieux A, Bouhour D, Biron F, Chidiac C, Peyramond D.
    Pathol Biol (Paris); 1999 May 27; 47(5):566-9. PubMed ID: 10418042
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection.
    Schürmann D, Bergmann F, Albrecht H, Padberg J, Wünsche T, Grünewald T, Schürmann M, Grobusch M, Vallée M, Ruf B, Suttorp N.
    Eur J Clin Microbiol Infect Dis; 2002 May 27; 21(5):353-61. PubMed ID: 12072919
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
    Nachman S, Gona P, Dankner W, Weinberg A, Yogev R, Gershon A, Rathore M, Read JS, Huang S, Elgie C, Hudgens K, Hughes W.
    Pediatrics; 2005 Apr 27; 115(4):e488-94. PubMed ID: 15772172
    [Abstract] [Full Text] [Related]

  • 12. Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapy.
    Grabar S, Lanoy E, Allavena C, Mary-Krause M, Bentata M, Fischer P, Mahamat A, Rabaud C, Costagliola D, Clinical Epidemiology Group of the French Hospital Database on HIV.
    HIV Med; 2008 Apr 27; 9(4):246-56. PubMed ID: 18366449
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. HIV-related nontuberculous mycobacterial infection: incidence, survival analysis and associated risk factors.
    Arastéh KN, Cordes C, Ewers M, Simon V, Dietz E, Futh UM, Brockmeyer NH, L'age MP.
    Eur J Med Res; 2000 Oct 30; 5(10):424-30. PubMed ID: 11076783
    [Abstract] [Full Text] [Related]

  • 15. Can data from an electronic medical record identify which patients with pneumonia have Pneumocystis carinii Infection?
    Diero L, Stiffler T, Einterz RM, Tierney WM.
    Int J Med Inform; 2004 Nov 30; 73(11-12):743-50. PubMed ID: 15491925
    [Abstract] [Full Text] [Related]

  • 16. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.
    Kaufmann GR, Furrer H, Ledergerber B, Perrin L, Opravil M, Vernazza P, Cavassini M, Bernasconi E, Rickenbach M, Hirschel B, Battegay M, Swiss HIV Cohort Study.
    Clin Infect Dis; 2005 Aug 01; 41(3):361-72. PubMed ID: 16007534
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
    Bedell R, Heath KV, Hogg RS, Wood E, Press N, Yip B, O'Shaughnessy MV, Montaner JS.
    Antivir Ther; 2003 Oct 01; 8(5):379-84. PubMed ID: 14640384
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.